Chrono-metabolism: What Can Metabolomics Tell Us About Sleep and Circadian Related Disease Processes?

Aalim M. Weljie, Ph.D. is a Research Assistant Professor of Systems Pharmacology and Translational Therapeutics at the Perelman School of Medicine at the University of Pennsylvania. He received his B.Sc. in Chemistry and Certificate in Engineering from Mount Allison University in New Brunswick, Canada in 1996, and his Ph.D. in Biochemistry from the University of Calgary, Canada in 2003. He completed an industrial post-doctoral fellowship with Chenomx Inc where he developed expertise in quantitative NMR metabolomics, followed by a visiting scientist fellowship from EMBO to the University of Cambridge in the lab of Dr. Jules Griffin. Dr. Weljie was the co-Director of the Metabolomics Research Center at the University of Calgary from 2008 until he was recruited to Penn in 2012 in Pharmacology and the Institute of Translational Medicine and Therapeutics. Dr. Weljies current research interests focus is Chrono-metabolomics, including translational studies of metabolism and molecular clocks, such as sleep disruption, circadian rhythms and the influence of diseases such as cancer on the clock-metabolism connection as well as aging processes. In addition to contributions to analytical methods for metabolomics, Dr. Weljie has reported novel cross-species biomarkers of sleep restriction, and the circadian nature of numerous metabolites in vitro and in vivo.

Contact

  Margaret Weber
  maw71@psu.edu
  814-865-7697